Regeneron Pharmaceuticals Inc

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid
Coronavirus chronicle

Regeneron's Covid antibody drug shows protection for up to 8 months

The therapy had previously shown an 81.4% risk reduction during the first month after administration

Eli Lilly and Regeneron Pharmaceuticals Inc. are asking the US government to allow emergency use of their antibody drugs, which aim to help the immune system clear the virus. Photo: AP
Coronavirus chronicle

Antibody drugs are no cure but seem promising for Covid-19